How many billions is enough? Prioritizing profits over patients with cystic fibrosis

被引：12

作者：

McGarry, Meghan E. ^{[1
,6
]}

Gibb, Elizabeth R. ^{[1
]}

Laguna, Theresa A. ^{[2
]}

O'Sullivan, Brian P. ^{[3
]}

Sawicki, Gregory S. ^{[4
]}

Zobell, Jeffery T. ^{[5
]}

机构：

[1] Univ Calif San Francisco, Dept Pediat, Div Pediat Pulm Med, San Francisco, CA USA

[2] Northwestern Univ, Dept Pediat, Div Pulm Med, Feinberg Sch Med, Chicago, IL USA

[3] Dartmouth Coll, Dept Pediat, Div Pediat Pulmonol, Geisel Sch Med, Hanover, NH USA

[4] Harvard Med Sch, Dept Pediat, Div Pulm Med, Boston, MA USA

[5] Univ Utah, Dept Pharmacotherapy, Salt Lake City, UT USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

PEDIATRIC PULMONOLOGY | 2023年 / 58卷 / 05期

基金：

美国国家卫生研究院;

关键词：

cystic fibrosis; ethics; personalized medicine; pharmacotherapy;

D O I：

10.1002/ppul.26335

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：1595 / 1597

页数：3

共 8 条

[1] Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease [J].

Burgel, Pierre-Regis ;

Durieu, Isabelle ;

Chiron, Raphael ;

Ramel, Sophie ;

Danner-Boucher, Isabelle ;

Prevotat, Anne ;

Grenet, Dominique ;

Marguet, Christophe ;

Reynaud-Gaubert, Martine ;

Macey, Julie ;

Mely, Laurent ;

Fenton, Annlyse ;

Quetant, Sebastien ;

Lemonnier, Lydie ;

Paillasseur, Jean-Louis ;

Da Silva, Jennifer ;

Martin, Clemence .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (01) :64-73

[2] Current prices versus minimum costs of production for CFTR modulators [J].

Guo, Jonathan ;

Wang, Junzheng ;

Zhang, Jingchun ;

Fortunak, Joseph ;

Hill, Andrew .

JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (05) :866-872

[3] Pregnancy among cystic fibrosis women in the era of CFTR modulators [J].

Heltshe, Sonya L. ;

Godfrey, Emily M. ;

Josephy, Tatiana ;

Aitken, Moira L. ;

Taylor-Cousar, Jennifer L. .

JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (06) :687-694

[4] Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis [J].

McGarry, Meghan E. ;

Gibb, Elizabeth R. ;

Oates, Gabriela R. ;

Schechter, Michael S. .

PAEDIATRIC RESPIRATORY REVIEWS, 2022, 42 :35-42

[5] Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele [J].

Middleton, P. G. ;

Mall, M. A. ;

Drevinek, P. ;

Lands, L. C. ;

McKone, E. F. ;

Polineni, D. ;

Ramsey, B. W. ;

Taylor-Cousar, J. L. ;

Tullis, E. ;

Vermeulen, F. ;

Marigowda, G. ;

Mckee, C. M. ;

Moskowitz, S. M. ;

Nair, N. ;

Savage, J. ;

Simard, C. ;

Tian, S. ;

Waltz, D. ;

Xuan, F. ;

Rowe, S. M. ;

Jain, R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (19) :1809-1819

[6]

Seyoum S., 2020, COST COVERAGE UNDERU

[7] The effectiveness and value of novel treatments for cystic fibrosis A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum [J].

Tice, Jeffrey A. ;

Kuntz, Karen M. ;

Wherry, Kael ;

Seidner, Matt ;

Rind, David M. ;

Pearson, Steven D. .

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (02) :276-280

[8]

Vertex Pharmaceuticals, 2022, VERT REP 3 QUART 202

← 1 →